Erectile dysfunction. Male erectile dysfunction, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Intervention group 1: Adenectomy surgery patients who will undergo manual therapy and exercise therapy. In these patients, the muscles of the ischiocaverenus and bu
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Confirmation of the absence of a secondary erection to prostate surgery by a physician Patients operated by retropubic technique with both adenectomy and radical methods Being married Age range between 45 to 60 years
Exclusion criteria
Exclusion criteria: Taking erectile drugs such as taladafil and sildenafil Mental problems such as depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erection hardness. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: Erection hardness score.;Erection index. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: International index of erectile function Questionnaire.;Maximum thickness of Ischiocavernus. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by two-dimensional ultrasound.;Maximum thickness of bulbouspongesios. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by two-dimensional ultrasound.;Area of Ischiocavernus. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by two-dimensional ultrasound.;Area of bulbouspongesios. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by two-dimensional ultrasound.;Maximum cavernosal systolic velocity. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by color ultrasound.;Minimum diastolic velocity of cavernosal artery. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by color ultrasound.;Cavernosal artery diameter. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by color ultrasound.;Maximum blood velocity in the posterior vein. Timepoint: Outcome will be measured at both the beginning and end of treatment. Method of measurement: measured by color ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Afshar Safavi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed